Duplios Reserve

DUPLIOS RESERVE

The index for the qualified digital economy.

BTC
$78,043
SOURCE
Binance BTCUSDT
QUOTE
USDT
OBSERVED
15:49 SAST
INGESTED
15:49 SAST
FRESHNESS
AGING
CROSS-CHECK
Coinbase · 0.04% · NORMAL
AGING
+0.15%
ETH
$2,444
SOURCE
Binance ETHUSDT
QUOTE
USDT
OBSERVED
15:49 SAST
INGESTED
15:49 SAST
FRESHNESS
AGING
CROSS-CHECK
Coinbase · 0.02% · NORMAL
AGING
-0.09%
SOL
$101.92
SOURCE
CoinGecko
QUOTE
USD
OBSERVED
15:47 SAST
INGESTED
15:49 SAST
FRESHNESS
STALE
STALE
-0.62%
XRP
$1.37
SOURCE
CoinGecko
QUOTE
USD
OBSERVED
15:47 SAST
INGESTED
15:49 SAST
FRESHNESS
STALE
STALE
+0.53%
BNB
$686.18
SOURCE
CoinGecko
QUOTE
USD
OBSERVED
15:47 SAST
INGESTED
15:49 SAST
FRESHNESS
STALE
STALE
-0.04%
DDEI
NOT PUBLISHEDUNAVAILABLE
DR
PAPER
TOTAL DIGITAL MARKET CAP
$2.64T
SOURCE
CoinGecko
OBSERVED
15:44 SAST
INGESTED
15:49 SAST
FRESHNESS
AGING
AGING
BTC DOMINANCE
59.1%
FEAR & GREED
69 Greed
SOURCE
alternative.me
OBSERVED
02:00 SAST
INGESTED
15:49 SAST
FRESHNESS
AGING
AGING
DATA STATUS
LIVE
LIVE
DR-LEGAL-0.1 · RESEARCH / PROVISIONAL — NOT LEGAL ADVICE

DR LEGAL CLASSIFICATION + JURISDICTION LAB

What legal and financial form correctly expresses the economic product already designed? Research only. Not legal advice. No token. No offer. No trading. No regulatory approval.

RESEARCH · SIMULATION · NOT INVESTMENT PERFORMANCE · NOT INVESTABLE · £0 REAL CAPITAL · PAPER
RESEARCH · NOT LEGAL ADVICE · NO TOKEN · NO OFFER · NO TRADING · NO REGULATORY APPROVAL · DR_MODE=PAPER · DDEI LIVE=FALSE · METHODOLOGY FROZEN=FALSE · REAL CAPITAL=£0 · COUNSEL=NONE APPOINTED · JURISDICTION SELECTED=FALSE · COUNSEL VERIFIED=FALSE

WHAT IS DR?

DR is intended to provide economic exposure to DDEI. DDEI is a rules-based digital-asset index under research. The lead economic architecture from the replication tournament is AP-funded full physical DDEI replication, with in-kind and cash creation/redemption, a segregated supporting portfolio, NAV, and secondary-market AP/MM arbitrage. That architecture is RESEARCH / PROVISIONAL. It is not approved or frozen.

  • BENCHMARK: Rules-based digital-asset index under research. Not live. Methodology not frozen. DR is never a constituent.
  • FUNDING: New DR creation requires corresponding funded economic exposure. No unfunded DR. Founder does not pre-fund eventual AUM.
  • RESERVES: Physical constituent assets are the lead research replication mechanism. No reserve exists today.
  • NAV: Supporting portfolio value / DR outstanding. NAV ≠ DDEI level ≠ market price.
  • ARBITRAGE: AP/MM creation/redemption is intended to constrain premium/discount inside all-in costs. Not guaranteed.

Lead architecture id: C_AP_FUNDED_PHYSICAL + I_INKIND_CR + J_CASH_CR. Status: RESEARCH / PROVISIONAL. Approved: FALSE. Frozen: FALSE.

WHY CLASSIFICATION MATTERS

Classification decides whether DR is an ordinary cryptoasset, a fund, a security, an ETP, an ART, or something else — and therefore which licences, holder rights, venues, and insolvency rankings apply. The question is not how to look like a coin. The question is which legal form correctly expresses the economics. Internal research cannot produce COUNSEL VERIFIED, COMPLIANT, or REGULATORY APPROVED.

CURRENT ECONOMIC ARCHITECTURE

DR is intended to provide economic exposure to DDEI via a funded supporting portfolio, not via an information token.

Creation: Cash and/or in-kind authorised-participant creation after funding and reconciliation.

Redemption: Cash and/or in-kind redemption subject to final legal architecture. No current redemption right.

Secondary market: Market price may differ from NAV.

  • No guaranteed return
  • No guaranteed market price
  • No guaranteed liquidity
  • No current redemption right
  • No current reserve
  • No current issuance
  • No current trading

UNRESOLVED DESIGN VARIABLES

Answers are not chosen to avoid regulation. None of these is a public holder right.

  • V01. Does every retail holder have direct redemption rights? Lead: UNRESOLVED — lead models AP-primary; retail direct is a variant.
  • V02. Are only APs able to redeem? Lead: RESEARCH ASSUMPTION: AP-primary, not a legal election.
  • V03. Does DR constitute a claim against issuer or against a reserve vehicle? Lead: UNRESOLVED
  • V04. Does the holder beneficially own reserve assets? Lead: UNRESOLVED — no silent beneficial-ownership grant.
  • V05. Is reserve property held on trust? Lead: NO TRUST EXISTS
  • V06. Is DR a debt obligation? Lead: NOT ELECTED
  • V07. Is DR a unit/interest in pooled property? Lead: ECONOMICALLY the book is pooled; LEGAL form UNRESOLVED
  • V08. Does the issuer exercise discretionary management? Lead: RESEARCH INTENT: rules-based replication of DDEI. DDEI itself is not frozen.
  • V09. Is DDEI methodology fully rules-based and frozen? Lead: NOT FROZEN
  • V10. Are staking rewards passed through to NAV/holders? Lead: UNRESOLVED — four research policies, none adopted
  • V11. Are assets segregated from issuer operating estate? Lead: NO SEGREGATED ACCOUNTS EXIST
  • V12. Is there a bankruptcy-remote vehicle? Lead: NO — do not label remote
  • V13. Is DR perpetual? Are there maturity rights? Lead: RESEARCH INTENT: open-ended / perpetual. NOT ELECTED LEGALLY
  • V14. Can issuer suspend redemption? Lead: UNRESOLVED
  • V15. Who bears custody losses, forks and airdrops? Lead: UNRESOLVED — forks not silently issuer revenue
  • V16. What happens in insolvency of issuer, SPV, custodian, or AP mid-creation? Lead: UNRESOLVED
  • V17. Is the instrument freely transferable on public chains to unknown persons? Lead: NO TOKEN; transferability UNRESOLVED

LEGAL CLASSIFICATION TREE

Status vocabulary: LIKELY / POSSIBLE / UNLIKELY / UNKNOWN / COUNSEL REQUIRED. Never a legal conclusion.

CategoryStatusWhy this is a question
Cryptoasset / virtual asset (generic)POSSIBLEIf DR is issued on a DLT as a transferable unit it may be a cryptoasset in several statutes. That does not exhaust classification. Tokenised specified investments may be carved out of ‘ordinary’ cryptoasset buckets (UK RAO art. 88F(4)(a) as inserted by SI 2026/102).
UK qualifying cryptoasset (RAO art. 88F, SI 2026/102)POSSIBLEFungible + transferable cryptoassets that are not excluded. If DR is a specified investment cryptoasset (security / CIS unit / contractually based investment), it is excluded from 88F. COUNSEL REQUIRED on the exclusion.
UK qualifying stablecoin (RAO art. 88G)UNLIKELYArt. 88G requires the cryptoasset to seek or purport to maintain a stable value in relation to a particular fiat currency, with assets held for that purpose. DR is designed to track a moving digital-asset index, not to peg a fiat. Art. 88G(3) also says a stable value vs a non-fiat asset is not 88G(2)(a). Not a legal conclusion.
EU MiCA asset-referenced tokenPOSSIBLEMiCA ART is a crypto-asset that is not an EMT and aims to maintain a stable value by referencing another value or right or combination, including official currencies. DR references a basket/index and holds corresponding assets — POSSIBLE ART. DR also aims to move with DDEI, not to ‘stabilise’ — which may cut against ART. MiCA Art. 2 may exclude financial instruments. Both forks are COUNSEL REQUIRED. Do not self-classify.
E-money token / e-money / single-currency stablecoinUNLIKELYNot designed as a surrogate for a single official currency. Cash used for settlement is not the product promise. Still COUNSEL REQUIRED if a fiat-redeemable cash product were substituted.
Stablecoin (generic)UNLIKELYLead architecture tracks a volatile index. Calling DR a stablecoin would be a false product description.
Security / tokenised security / transferable securityPOSSIBLEPooled capital, NAV, expected profits from others’ management/replication, and transferability are classic securities-analysis facts in several systems (US Howey/Reves; EU transferable securities; UK specified investments). No Howey-hack. COUNSEL REQUIRED.
Debt security / note / ETNPOSSIBLEOnly if DR is structured as an issuer obligation to pay a DDEI-linked amount. Lead architecture is physical pooled assets, not an unsecured promise. Variant F would move here.
Collective investment scheme / fund / AIF / unit in pooled assetsLIKELYLead economics: investors’ money/assets pooled, no day-to-day holder control, returns depend on a managed/replicated portfolio. UK FSMA s.235 is broad. SI 2026/102 CIS exclusion for ‘qualifying stablecoin arrangements’ would not obviously apply if DR is not a 88G stablecoin. LIKELY is a research flag, not a conclusion. COUNSEL REQUIRED.
ETF-like product / ETP / exchange-traded commodity trustPOSSIBLEAP creation/redemption + NAV + secondary trading is the ETP operating system. US commodity-based trust shares (SEC generic listing standards, 2025) are an institutional analogue for spot digital-asset baskets — not a Duplios listing. COUNSEL REQUIRED.
Structured product / derivative / commodity-linked instrumentPOSSIBLEIf exposure is synthetic (killed as lead) or if DR is a note on DDEI. Physical replication with AP C/R more often analysed as fund/ETP than as a derivative, but commodity-interest questions remain in the US. COUNSEL REQUIRED.
Investment contract (US)POSSIBLEDo not attempt to Howey-hack. Pooled DDEI exposure sold to holders expecting NAV-tracking profits from a replicating portfolio is a fact pattern counsel must test under Securities Act / Exchange Act / Investment Company Act. US access may be restricted. That is acceptable if legally prudent.
Digital asset certificate / depositary receiptPOSSIBLEA certificate representing a claim on a basket is a known traditional form. Would still be a regulated instrument in most markets.
Ordinary freely transferable ‘crypto coin’ with no fund/security wrapperUNLIKELYThe surviving economic machine is funded pooled NAV + C/R. Dressing that as an ordinary coin does not remove pooling. UK tokenised specified investments are carved out of qualifying cryptoassets. This is the red-flag form.

HOLDER RIGHTS

A model is not a grant. No current redemption right. MODELED NOT GRANTED means the replication lab used the mechanic as an economic hypothesis only.

RightLead assumes?ProtectionIssuer riskClassification implication
NAV claim (economic)MODELED NOT GRANTEDHIGHMEDIUMNAV + pooling is a CIS/fund fact.
Redemption (any)NOHIGHHIGHPresence, holder class, and price (NAV vs par) change ART/CIS/debt analysis.
Cash redemptionMODELED NOT GRANTEDMEDIUMHIGHCash at NAV looks fund-like; cash at par looks stablecoin-like (not this product).
In-kind redemptionMODELED NOT GRANTEDMEDIUMMEDIUMDoes not by itself avoid CIS.
VotingNOMEDIUMMEDIUMVoting + pooled assets can look more CIS/corporate.
Reserve beneficial ownershipNOHIGHLOWBeneficial ownership ≠ ordinary coin.
Insolvency rights / rankingUNRESOLVEDHIGHHIGHCreditor vs beneficiary vs unit-holder.
Distribution / staking incomeUNRESOLVEDMEDIUMMEDIUMPass-through income is a CIS fact.
Forks / airdropsUNRESOLVEDMEDIUMMEDIUMUnexpected distributions look fund-like.
Information rightsUNRESOLVEDHIGHLOWPeriodic disclosure is a regulated-product hallmark.
Audit accessNOHIGHLOWDoes not change form by itself.
TransferabilityUNRESOLVEDMEDIUMHIGHPermissioned unit vs ordinary coin.
Suspension of C/RUNRESOLVEDMEDIUMMEDIUMGates are a fund fact.
Termination / wind-downUNRESOLVEDHIGHHIGHMaturity vs perpetual open-end.

RESERVE OWNERSHIP

No reserve exists. No custodian. No trust. No SPV. Variants A–J change who owns BTC/ETH/etc. and how holders rank. Beneficial ownership is not implied by a paper NAV. Bankruptcy-remoteness is not a status this lab can assign.

  • A. Issuer owns reserve assets — protection LOW. Holders look like unsecured creditors unless a trust/security interest is layered on.
  • B. Separate reserve SPV — protection MEDIUM. May isolate operating-company creditors; does not by itself create beneficial ownership for holders.
  • C. Bankruptcy-remote SPV concept — protection UNKNOWN. A label, not a legal fact. Forbidden as a claim without external opinion.
  • D. Trustee-held reserve — protection HIGH. Points toward trust/ETP/fund; trustee duties and indenture become central.
  • I. Direct beneficial interest in reserve — protection HIGH. Trust/co-ownership. Still usually a CIS if pooled and managed.
  • J. Contractual claim against issuer — protection LOW. Unsecured debt-like. Insolvency ranking poor.

INSOLVENCY

HARD BLOCKER. If Duplios failed tomorrow, ranking of DR holders is unknown. These are counsel questions, not answers.

  • If Duplios fails tomorrow, who legally owns BTC/ETH/etc. held as a supporting portfolio?
  • Can Duplios creditors seize those assets?
  • Do DR holders rank as secured creditors, unsecured creditors, beneficial owners, fund unit-holders, trust beneficiaries, or none of these?
  • What happens if the custodian fails? (None is appointed.)
  • What happens if the issuer fails?
  • What happens if a reserve SPV fails?
  • What happens if an AP fails mid-creation?
  • What happens if redemption has been locked but not settled?
  • What happens if a fork or airdrop lands during insolvency?

JURISDICTIONS

Shortlist for external counsel review is not domicile selection. No jurisdiction is SELECTED.

United Kingdom · FCA / HM Treasury · SELECTED=FALSE

UK has special priority because the crypto perimeter changed in 2026. Application window opens 30 Sep 2026. This memo is not an application.

  • Qualifying stablecoin (88G): UNLIKELY — Moving index, not a fiat peg. 88G(3) non-fiat reference is not 88G(2)(a).
  • Qualifying cryptoasset (88F): POSSIBLE — Only if not a specified investment cryptoasset and 88F(2)(c) is met.
  • Specified investment cryptoasset / CIS unit: LIKELY — Pooled NAV + C/R. Research flag. COUNSEL REQUIRED.
  • Issuing qualifying stablecoin (9M): UNLIKELY — 9M needs a redeem undertaking to maintain stable value.
  • Safeguarding (9N) / dealing / arranging / platform (9S): POSSIBLE — If a qualifying cryptoasset exists and UK activities occur.
  • Financial promotions: LIKELY — Any UK marketing of a cryptoasset is already in scope of the promotions regime. COUNSEL REQUIRED.
  • Prospectus / listing: POSSIBLE — If transferable security / admitted to a UK trading venue.
  • Benchmark administrator: POSSIBLE — If DDEI is used in a financial instrument offered in the UK.

Official sources retrieved 2026-09-01. Hashes are of URLs, not of legal opinions.

  • HM Treasury / UK legislation: Financial Services and Markets Act 2000 (Cryptoassets) Regulations 2026 (SI 2026/102) (2026-02-04) — https://www.legislation.gov.uk/uksi/2026/102/pdfs/uksi_20260102_en.pdf
  • HM Treasury: Explanatory Memorandum to SI 2026/102 (2026-02-04) — https://www.legislation.gov.uk/uksi/2026/102/pdfs/uksiem_20260102_en_001.pdf
  • FCA: New regime for cryptoasset regulation (hub) (2026-06-30) — https://www.fca.org.uk/firms/new-regime-cryptoasset-regulation
  • UK legislation: FSMA 2000 s.235 Collective investment schemes (2000-06-14) — https://www.legislation.gov.uk/ukpga/2000/8/section/235
  • FCA: FG23/3 Finalised Guidance — financial promotions on social media / crypto promotions context (2023-03-20) — https://www.fca.org.uk/publication/finalised-guidance/fg23-3.pdf
  • UK legislation: Financial Services and Markets Act 2000 (Collective Investment Schemes) (Amendment) Order 2025 (SI 2025/17) (2025-01-15) — https://www.legislation.gov.uk/uksi/2025/17/contents/made

European Union (MiCA + financial-instrument law) · ESMA / EBA / NCAs · SELECTED=FALSE

Do not treat ‘EU’ as a single issuer domicile. Ireland/Luxembourg would be fund-domicile questions for later counsel, not selections.

  • MiCA ART: POSSIBLE — Basket reference + reserve. ‘Stabilise’ vs ‘track’ is the definitional fight.
  • MiCA EMT: UNLIKELY — Not a single official-currency surrogate.
  • Other crypto-asset (Title II): POSSIBLE — Only if not ART/EMT and not a financial instrument.
  • Financial instrument / fund / ETP (outside MiCA): POSSIBLE — Art. 2 exclusion. May be the honest form.

Official sources retrieved 2026-09-01. Hashes are of URLs, not of legal opinions.

  • European Union: Regulation (EU) 2023/1114 (MiCA) (2023-05-31) — https://eur-lex.europa.eu/legal-content/en/TXT/?uri=CELEX%3A32023R1114

Dubai / VARA · VARA · SELECTED=FALSE

Do not infer VARA ARVA approval from terminology overlap.

  • Asset-referenced VA: POSSIBLE — Terminology overlap only. Not approval.
  • VA issuance / brokerage / custody: POSSIBLE — If issued or offered in Dubai.

Official sources retrieved 2026-09-01. Hashes are of URLs, not of legal opinions.

  • VARA: VARA Rulebooks (including VA Issuance) (2023-02-07) — https://rulebooks.vara.ae/

Abu Dhabi / ADGM / FSRA · FSRA · SELECTED=FALSE

Do not treat Dubai and Abu Dhabi as one jurisdiction.

  • Virtual asset: POSSIBLE — Guidance VER07.100625.
  • Digital security / fund unit: POSSIBLE — If pooled NAV is a security/collective investment.

Official sources retrieved 2026-09-01. Hashes are of URLs, not of legal opinions.

  • ADGM FSRA: Guidance — Regulation of Virtual Asset Activities in ADGM (VER07.100625) (2025-06-10) — https://assets.adgm.com/download/assets/Guidance+-+Regulation+of+Virtual+Asset+Activities+in+ADGM+(VER07.100625)+.pdf/f7702902704711efa4c3fe3e7821af93

Switzerland / FINMA · FINMA · SELECTED=FALSE

Credible institutional option; not selected.

  • Payment token: UNLIKELY — Not a means of payment.
  • Asset token / security: POSSIBLE — Claim on assets or issuer.
  • CISA collective investment: POSSIBLE — FINMA basket+redemption mapping. COUNSEL REQUIRED.

Official sources retrieved 2026-09-01. Hashes are of URLs, not of legal opinions.

  • FINMA: Supplement to the ICO guidelines — stablecoins (11 Sep 2019) (2019-09-11) — https://www.finma.ch/en/~/media/finma/dokumente/dokumentencenter/myfinma/1bewilligung/fintech/wegleitung-stable-coins.pdf

Singapore / MAS · MAS · SELECTED=FALSE

Do not assume DPT treatment because DR would sit on a blockchain.

  • Digital payment token: UNLIKELY — Index-NAV claim is not a payment token by design.
  • Capital markets product / CIS: POSSIBLE — Tokenisation of CMPs guide.

Official sources retrieved 2026-09-01. Hashes are of URLs, not of legal opinions.

  • MAS: Guide on the Tokenisation of Capital Markets Products (2025-11-14) — https://www.mas.gov.sg/regulation/guidelines/guide-on-tokenisation-of-cmps

Hong Kong / SFC · SFC / HKMA · SELECTED=FALSE

Shortlisted for counsel because the authorised-product analogue matches the economics. Not selected as domicile.

  • Authorised VA fund / ETP: POSSIBLE — Closest honest form for the AP+NAV machine.
  • Ordinary VA coin on a VATP: UNLIKELY — Pooled NAV product is not a simple VA.

Official sources retrieved 2026-09-01. Hashes are of URLs, not of legal opinions.

  • SFC: Regulatory requirements — virtual assets / authorised funds with VA exposure (2023-12-22) — https://www.sfc.hk/en/Welcome-to-the-Fintech-Contact-Point/Virtual-assets/Other-virtual-asset-related-activities/Regulatory-requirements

United States / SEC / CFTC · SEC / CFTC · SELECTED=FALSE

Not in the top-3 counsel domicile shortlist. A parallel US opinion is still warranted if any US person could receive DR.

  • Investment contract: POSSIBLE — No Howey-hack. COUNSEL REQUIRED.
  • Investment company (1940 Act): POSSIBLE — Pooled securities/crypto portfolio.
  • Commodity-based trust / ETP: POSSIBLE — SEC generic listing standards 2025 are the analogue, not a Duplios listing.
  • Ordinary coin: UNLIKELY — Red-flag form for this economics.

Official sources retrieved 2026-09-01. Hashes are of URLs, not of legal opinions.

  • SEC: SEC approves generic listing standards for Commodity-Based Trust Shares (17 Sep 2025) (2025-09-17) — https://www.sec.gov/newsroom/press-releases/2025-121-sec-approves-generic-listing-standards-commodity-based-trust-shares

South Africa / FSCA · FSCA / FIC · SELECTED=FALSE

Relevant because NAV timezone is Africa/Johannesburg. Not an automatic domicile.

  • Crypto-asset financial product (FAIS): POSSIBLE — FSCA declaration 19 Oct 2022.
  • CISCA collective investment: POSSIBLE — Pooled scheme question. COUNSEL REQUIRED.
  • Direct SA retail offer: UNKNOWN — Never claim retail. COUNSEL REQUIRED.

Official sources retrieved 2026-09-01. Hashes are of URLs, not of legal opinions.

  • FSCA: General Notice 1350 of 2022 — Declaration of a crypto asset as a financial product (Gazette 47334) (2022-10-19) — https://www.gov.za/sites/default/files/gcis_document/202210/47334gen1350.pdf

UK — SPECIAL PRIORITY OUTPUTS

UK_PRODUCT_CLASSIFICATION_QUESTIONS

  • CIS under FSMA s.235?
  • Specified investment / specified investment cryptoasset?
  • Qualifying cryptoasset (88F) after exclusions?
  • Qualifying stablecoin (88G)? (Research: UNLIKELY fit.)
  • Transferable security / prospectus?
  • Derivative / structured product?
  • Benchmark used in a financial instrument?
  • Does the new crypto regime apply in addition to, or instead of, the above? (Research: in addition, not instead.)

UK_AUTHORISATION_PATHS

  • Do nothing / remain PAPER and non-offering — current fact.
  • CIS / AIF / authorised-fund path with depositary and manager.
  • ETP / listed-fund / listed-note path.
  • RAO crypto-activity path (only if still a qualifying cryptoasset after exclusions).
  • Dual CIS + crypto RAO path if activities overlap.
  • Refuse UK persons / geofence — a distribution choice, not a classification.

UK_BLOCKERS

  • No counsel.
  • No issuer vehicle designed.
  • No depositary/trustee.
  • Methodology unfrozen.
  • No application has been or will be submitted by this research.
  • Gateway window (30 Sep 2026–28 Feb 2027) is calendar fact, not a Duplios plan.

DDEI BENCHMARK QUESTIONS

  • If DR (or any financial instrument) references DDEI, is DDEI a ‘benchmark’ under UK and EU benchmark frameworks?
  • Can Duplios calculate DDEI internally, or is an independent administrator required?
  • Would an external calculation agent materially strengthen institutional acceptance even if not legally required?
  • Conflicts: Duplios designs DDEI and would issue DR — IOSCO-aligned independence is currently unmet (DDEI-IOSCO-0.1).
  • Error correction, reconstitution, and market-impact controls as legal vs operational duties.

COUNSEL REQUIRED where DDEI is used in a financial instrument.

PRODUCT STRUCTURES

Ordinary crypto coin still make sense? NO.

Research finding, not a legal conclusion: the surviving economic architecture is funded pooled DDEI exposure with NAV and AP creation/redemption. That is the operating system of a fund/ETP/certificate, not of an ordinary transferable coin. UK SI 2026/102 also carves tokenised specified investments out of the ordinary qualifying-cryptoasset bucket. If counsel later opines that a non-fund form is available, that opinion must be written against these exact economics — not against a redesigned product.

  • Native freely transferable crypto token. Delivers the promise: WEAK — transferability is not the product; funded DDEI exposure is. Red-flag form if the book is a pooled NAV portfolio.
  • Tokenized fund interest / regulated fund share. Delivers the promise: STRONG — the product is pooled NAV exposure. On-chain unit of a fund. Transfer may be restricted.
  • Tokenized ETP / certificate / conventional ETP with blockchain representation. Delivers the promise: STRONG — AP C/R + NAV + secondary market is the ETP machine. Likely the closest operational match to the lead architecture.
  • Tokenized note / ETN. Delivers the promise: PARTIAL — exposure yes; issuer credit risk is not the current economic story. Weaker protection unless collateralised and opined.
  • Dual traditional + on-chain representation. Delivers the promise: STRONG — same legal instrument, two settlement rails. Highest operational burden; highest institutional compatibility.

VARIANTS A–O

  • A. Issuer owns reserve assets — credibility LOW, protection LOW. Simplest corporate picture; weakest insolvency story.
  • B. Separate reserve SPV — credibility MEDIUM, protection MEDIUM. SPV failure is a separate insolvency case.
  • C. Bankruptcy-remote SPV concept — credibility MEDIUM, protection UNKNOWN. Do not use the phrase as a status.
  • D. Trustee-held reserve — credibility HIGH, protection HIGH. Institutional default for commodity trusts.
  • E. Fund structure — credibility HIGH, protection HIGH. Honest expression of pooled NAV.
  • F. Note/debt structure — credibility MEDIUM, protection LOW. Weaker holder protection than a fund/trust unless secured.
  • G. Tokenized fund unit — credibility HIGH, protection HIGH. On-chain representation of a fund, not a coin.
  • H. Tokenized certificate / ETP — credibility HIGH, protection HIGH. Matches the lead economic machine.
  • I. Direct beneficial interest in reserve — credibility HIGH, protection HIGH. Must be documented; cannot be implied from NAV.
  • J. Contractual claim against issuer — credibility LOW, protection LOW. Do not market as ‘backed’ if this is the legal form.
  • K. AP-only redemption — credibility HIGH, protection MEDIUM. Lead research operating assumption, not a legal election.
  • L. Retail direct redemption — credibility MEDIUM, protection HIGH. Do not add this right silently on public pages.
  • M. Exchange-only secondary trading — credibility MEDIUM, protection MEDIUM. Do not claim a listing.
  • N. Fully physical — credibility HIGH, protection HIGH. Lead research replication.
  • O. Optimised replication — credibility MEDIUM, protection MEDIUM. KEEP as future research, not lead.

DISTRIBUTION

Never claim retail availability. PLAUSIBLE is not permission.

JurisdictionInstitutionalRetailGlobal
United KingdomCOUNSEL REQUIREDCOUNSEL REQUIREDUNLIKELY
European Union (MiCA + financial-instrument law)COUNSEL REQUIREDCOUNSEL REQUIREDUNLIKELY
Dubai / VARARESTRICTEDCOUNSEL REQUIREDUNLIKELY
Abu Dhabi / ADGM / FSRARESTRICTEDCOUNSEL REQUIREDUNLIKELY
Switzerland / FINMACOUNSEL REQUIREDCOUNSEL REQUIREDUNLIKELY
Singapore / MASRESTRICTEDCOUNSEL REQUIREDUNLIKELY
Hong Kong / SFCRESTRICTEDCOUNSEL REQUIREDUNLIKELY
United States / SEC / CFTCUNLIKELYCOUNSEL REQUIREDUNLIKELY
South Africa / FSCACOUNSEL REQUIREDCOUNSEL REQUIREDUNLIKELY

EXCHANGE COMPATIBILITY

  • Do not contact venues. Do not claim Binance or any listing.
  • If DR is a specified investment / fund unit / ETP, the correct venue family is a regulated securities/ETP market or a licensed platform that admits that instrument — not an ordinary spot-token list.
  • Crypto-exchange spot lists typically assume a freely transferable virtual asset. That assumption is the red-flag form for this economics.
  • US analogue (SEC 2025 generic listing standards) is commodity-based trust shares — an ETP, not a coin.
  • Hong Kong analogue is SFC-authorised VA funds/ETPs on licensed VATPs.
  • Transfer restrictions, KYC, AP/MM agreements, and jurisdictional geofencing are expected on the honest form.

Listing: NONE. No venue has been contacted. No listing is inferred from this page.

TAX QUESTIONS

TAX COUNSEL / ACCOUNTANT REQUIRED. Not tax advice.

Issuer

  • Corporation tax on reserve rebalances and tracking trades.
  • Tax treatment of staking, forks, airdrops at issuer vs vehicle.
  • Fees (management, creation, redemption) — income vs VAT/GST.
  • Token issuance itself — is there a taxable event?
  • Withholding on cross-border distributions.
  • Transfer pricing if multiple Duplios entities exist later.

Holder

  • Is secondary-market disposal a capital gain, income, or neither until classified?
  • Is redemption a disposal of the token, of an aliquot share, or of underlying assets?
  • Are NAV-accreted staking rewards income to the holder before redemption?

AP

  • In-kind creation/redemption — taxable transfer vs non-recognition.
  • Basket contribution basis and tracking-error true-up.

COUNSEL QUESTIONS

Thirty scoped questions for a firm to quote. Not submitted. Counsel: NONE APPOINTED.

  1. Under FSMA s.235, would an instrument whose economics are: (i) holders’ cash/crypto pooled into a supporting portfolio of DDEI constituents, (ii) no holder day-to-day control, (iii) NAV = portfolio/DR outstanding, (iv) AP cash and in-kind creation/redemption, constitute a collective investment scheme, and does the SI 2026/102 art. 3A qualifying-stablecoin exclusion apply to an index tracker that is not a fiat peg?
  2. Would that same instrument be a specified investment cryptoasset excluded from RAO art. 88F qualifying cryptoasset by art. 88F(4)(a), and does art. 88F(2)(c) (‘not solely a record of value or contractual rights’) independently exclude it?
  3. Does RAO art. 88G (qualifying stablecoin) apply to a token that seeks to track a moving digital-asset index rather than maintain a stable value vs a particular fiat currency, given art. 88G(3)?
  4. If the instrument is a CIS and/or specified investment, which UK authorisations (AIFM, depositary, RAO crypto activities 9M–9S, arranging, dealing, safeguarding, operating a trading platform) would be required for issuer, reserve vehicle, AP, custodian, and website operator?
  5. Would UK public-offer prohibition (SI 2026/102 reg. 10) and/or the financial-promotions regime (including FG23/3) prohibit a public transferable token of this economics, even if no UK ‘listing’ is sought?
  6. Under MiCA, is an index-referenced token backed by the index constituents an asset-referenced token (Art. 3), another crypto-asset, or a financial instrument excluded by Art. 2? Please apply Arts 36–39 (reserve, custody, investment of reserve, redemption) only if ART remains live after the Art. 2 analysis.
  7. If MiCA ART were hypothetically in play, can the reserve be a replicating crypto basket of DDEI constituents, or do Arts 36–38 force a different reserve composition that would break the product promise?
  8. Does restricting redemption to authorised participants (no retail direct redemption) change UK CIS, MiCA ART, or US investment-company analysis, and if so how?
  9. Does placing reserve assets in a separate SPV, without a trust, change holder ranking on issuer insolvency, or do holders remain unsecured creditors of the issuer?
  10. What documents (trust deed, security interest, fund instrument) would be required for holders to be beneficial owners of reserve assets rather than creditors, and what local licences would a trustee need?
  11. Would a tokenized fund unit or tokenized ETP certificate be a more accurate legal expression of these economics than a freely transferable crypto token, in the UK, EU, and Hong Kong?
  12. Under US law, would issuance or offering of this instrument (even from a non-US issuer) create Securities Act, Exchange Act, or Investment Company Act questions, and is the honest analogue a commodity-based trust ETP rather than a coin? Do not provide a Howey workaround.
  13. Where is the SEC/CFTC boundary for a physically backed digital-asset index product with AP creation/redemption?
  14. Does calculation and publication of DDEI by Duplios, if DR or any financial instrument references DDEI, create UK and/or EU benchmark-administrator obligations, and is an independent administrator or calculation agent required for institutional use?
  15. What whitepaper, prospectus, or equivalent disclosure document is required in the UK, EU, and Hong Kong for each plausible form (ART, other crypto-asset, CIS unit, ETP, note)?
  16. What own-funds / prudential / depositary capital requirements would apply to the issuer and reserve vehicle in each plausible UK and EU path?
  17. Must the custodian be locally licensed in the issuer’s jurisdiction, and can a sub-custodian model satisfy segregation for insolvency purposes?
  18. If Duplios Ltd (or a future issuer) fails tomorrow, who owns BTC/ETH/etc. held as a supporting portfolio, can operating creditors seize them, and how do DR holders rank (secured, unsecured, beneficiaries, unit-holders, or none)? Same questions for custodian failure, reserve-SPV failure, AP failure mid-creation, and redemption instructed but not settled.
  19. Is any structure we might describe as ‘bankruptcy remote’ actually remote as a matter of English (or other governing) insolvency law, and what opinion language is available?
  20. May this instrument be admitted to (a) a UK/EU regulated market or MTF as an ETP, (b) a crypto trading platform as a qualifying cryptoasset, or (c) both, and which is the correct venue family?
  21. Is marketing or offering to retail in the UK, EU, Hong Kong, Singapore, Dubai, ADGM, or South Africa permissible for any of the plausible forms, and under what authorisations? Do not assume retail availability.
  22. Under South African FAIS (crypto assets as financial products), CISCA, and FIC, would issuance, marketing, advice, or intermediation of DR to SA persons require authorisation, and can it be offered directly to SA retail?
  23. Under VARA rulebooks, does this product match asset-referenced VA issuance, another VA activity, or a security/fund analogue, and what Dubai-resident offering restrictions apply? Analyse separately from ADGM FSRA digital-securities / VA / fund tracks.
  24. Under MAS, is this a digital payment token, a capital-markets product (including CIS), or both, and what retail restrictions follow?
  25. Under FINMA categories and CISA, does a basket with NAV-dependent creation/redemption constitute collective investment, an asset token, or another category, and is a Swiss fund a credible institutional wrapper?
  26. What transfer restrictions, KYC, and allowlisting would be legally required if the instrument is a security/fund unit represented on a public chain?
  27. Who bears custody loss, slashing, forks, and airdrops as a matter of property and contract if those events are not allocated in a current instrument (there is none)?
  28. Would granting retail direct redemption, or conversely AP-only redemption plus free secondary transfer, be the classification-determinative right in the UK and EU?
  29. Is an independent index administrator required, or may Duplios calculate DDEI internally with a calculation agent, for the product to be institutionally acceptable and legally usable as a benchmark?
  30. Please scope a written opinion covering: (a) classification in UK, EU, and Hong Kong; (b) insolvency ranking under the recommended wrapper; (c) authorisations; (d) whether an ordinary crypto coin is a lawful expression of these economics. Quote the work. Do not treat this research as facts you must accept.

TOP 3 COUNSEL JURISDICTIONS

For external counsel review only. Not final domicile. SELECTED = FALSE for each.

1. United Kingdom

Why shortlisted: Official dual-track text is current and dated (SI 2026/102; FCA final rules 30 Jun 2026; gateway 30 Sep 2026–28 Feb 2027).

Serious disadvantage: New crypto regime does not displace CIS/securities/benchmark law.

2. European Union (MiCA + financial-instrument law)

Why shortlisted: Largest regulated crypto + fund market; passporting if a fund/ETP form is elected.

Serious disadvantage: ART vs financial-instrument fork is unresolved and outcome-determinative.

3. Hong Kong / SFC

Why shortlisted: Closest official analogue for a retail-capable crypto-index product is an authorised fund/ETP, not a spot coin.

Serious disadvantage: Retail access, if ever, is through authorised products and licensed platforms — not a global unrestricted token.

RANKINGS (RESEARCH SCORING, NOT APPROVAL)

Two rankings. Not collapsed. Do not pick easiest.

A — PRODUCT QUALITY

FormTotalNote
Dual traditional + on-chain representation70Highest quality; heaviest build.
Tokenized ETP / certificate (AP C/R)66Best match to the lead economic machine.
Regulated fund / tokenized fund unit62Strongest classic investor-protection wrapper.
Trustee-held reserve (unlisted)53Protection without a listing is still a trust/fund fact.
Tokenized note / ETN43Credit risk is not the current economic story.
Issuer-owned book + contractual claim30Weak insolvency; easy to over-claim ‘backing’.
Ordinary freely transferable crypto coin28Distribution theatre without the legal form of the product.

B — EXECUTION BURDEN

FormTotalNote
Dual traditional + on-chain representation76Do not pick this because it is heavy; pick it only if quality requires it.
Tokenized ETP / certificate (AP C/R)70High burden, high product quality.
Regulated fund / tokenized fund unit68Similar burden family to ETP.
Trustee-held reserve (unlisted)54Still not ‘just a coin’.
Tokenized note / ETN50Prospectus/note issuance is not light.
Issuer-owned book + contractual claim40Looks cheaper; insolvency and classification risk are not priced here.
Ordinary freely transferable crypto coin20Lowest listed burden is a trap if the product is actually a fund/ETP.

PARETO FRONTIER

  • Tokenized ETP / certificate: Highest quality among forms that already match AP C/R + NAV + secondary market. Burden is high and should be paid if this is the product.
  • Regulated fund / tokenized fund unit: Peer quality on protection; slightly less native to AP C/R listing rails; still on the frontier.
  • Dual traditional + on-chain: Quality-maximising point. Dominates on quality; dominated on burden. Keep if global rails require it.
  • Trustee-held unlisted reserve: Interior but not dominated on protection-per-burden if listing is deferred. Still COUNSEL REQUIRED.

HARD BLOCKERS

  • HB-COUNSEL: No external legal opinion exists. Internal research cannot create COUNSEL VERIFIED.
  • HB-CIS: Pooled physical NAV + AP C/R is a live CIS/fund/AIF question in the UK and analogue questions elsewhere.
  • HB-INSOLVENCY: Holder ranking on issuer/custodian/SPV/AP failure is unknown. No bankruptcy-remote claim.
  • HB-RIGHTS: No holder instrument exists. Rights cannot be inferred from a lab model.
  • HB-RESERVE: No reserve, custodian, bank, or auditor exists.
  • HB-FORM: Ordinary freely transferable crypto coin is a poor expression of the lead economics (research finding).
  • HB-BENCHMARK: DDEI is not live, not frozen, and has no independent administrator.
  • HB-PROMOTION: This lab is research. It is not an offer, whitepaper for subscription, or financial promotion.

RECOMMENDATION

The economics are those of a funded pooled DDEI tracker with AP creation/redemption. The form that correctly expresses that machine is a regulated tokenized fund/ETP/certificate — not an ordinary freely transferable crypto coin. COUNSEL REQUIRED. Not selected. Not approved.

Remain PAPER / £0. Commission external counsel against the exact economics and the 30 scoped questions. Do not issue DR, do not contact regulators from this lab, do not restructure any company, do not add public holder rights.

Jurisdiction selected: FALSE · Ordinary coin: NO · Legal conclusion: NO

Related research: /lab/dr-replication. Internal counsel briefing pack is not a public document.